Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial comparing mulberry twig alkaloid tablet to canagliflozin in adults with type 2 diabetes is ongoing or not yet updat…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: RISE Adult Medication Study [Phase 3]
Phase 3 results for the RISE Adult Medication Study (RISE Study Group) have been completed and posted, involving prediabetes and type 2 diab…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial update evaluating the efficacy of ursodeoxycholic acid (UDCA) in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes [Phase 4]
Phase 4 trial update exploring whether hematopoietic stem cell factors influence residual inflammatory cardiovascular risk in individuals wi…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial update for Tangningtongluo Tablet evaluating treatment for non-proliferative diabetic retinopathy in patients with ty…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2023-05-04EMA Withdrawn: Pioglitazone Teva (pioglitazone hydrochloride) — Teva B.V.
Pioglitazone Teva (pioglitazone hydrochloride) has been withdrawn from the European market.
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: SGLT2 Inhibition: Uric Acid Excretion Study [Phase 4]
Phase 4 clinical trial update on SGLT2 inhibition evaluating uric acid excretion in individuals with type 2 diabetes.
-
CLINICAL_TRIALS research · 2023-05-01Clinical Trial Update: Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. [Phase 4]
Phase 4 clinical trial investigating renal oxygenation, oxygen consumption, and hemodynamic kinetics in type 2 diabetes treated with ertugli…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Role of BCAA in Glucose Homeostasis [Phase 4]
A Phase 4 clinical trial from Maastricht University is exploring the role of branched-chain amino acids (BCAA) in glucose homeostasis for ty…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update for RO 205-2349 in patients with type 2 diabetes mellitus assessing efficacy, safety, tolerability, and pharmacokinetic…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. [Phase 2, Phase 3]
A Phase 2/3 trial evaluated corticosteroid injection combined with cataract surgery in diabetic eyes; the study is completed.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes [Phase 2]
Phase 2 trial update comparing HR17031, INS068, and SHR20004 injections for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Diabetes Homeless Medication Support Single Arm Treatment Development Trial [NA]
A single-arm clinical trial involving homeless individuals with Type 2 diabetes has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating a combination of botanicals (Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients [Phase 2]
Phase 2 trial investigating the efficacy and tolerance of liraglutide for weight loss in obese patients with type 2 diabetes undergoing hemo…
-
FDA approval · 2023-04-11FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental ANDA for Colesevelam Hydrochloride, allowing the marketing of a generic Colesevelam Hydrochloride produ…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men [Phase 4]
Phase 4 trial evaluating the effects of high-intensity statin therapy on steroid hormones and vitamin D in men with type 2 diabetes and dysl…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China [Phase 3]
Phase 3 trial evaluating a biosimilar insulin degludec/insulin aspart (22011) vs Ryzodeg in adults with type 2 diabetes in China.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Effects of DPP-4 Inhibition on Triglycerides [Phase 4]
Phase 4 trial evaluating the effects of DPP-4 inhibition on triglyceride levels in patients with type 2 diabetes and hypertriglyceridemia is…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin [Phase 3]
Phase 3 clinical trial update for SAL067 in patients with Type 2 diabetes not controlled by metformin has completed.
-
CLINICAL_TRIALS research · 2023-03-31Clinical Trial Update: An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants [Phase 2]
A Phase 2 add-on trial (FIGARO-BM) investigated the relationship between blood biomarkers and finerenone in participants from FIGARO-DKD (CK…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol [Phase 2]
Phase 2 extension trial update for inclisiran in participants with cardiovascular disease and high cholesterol; study completed with results…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]
Phase 3 trial update for SAL067 in adults with type 2 diabetes not controlled by diet and exercise (completed).
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes [Phase 1]
Phase 1 trial update of tirzepatide (LY3298176) in Japanese participants with type 2 diabetes completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial [Phase 4]
Phase 4 trial update assessing left ventricular function changes in uncontrolled diabetes with dapagliflozin treatment.